Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 33Uterine Cervical Neoplasms 29Endometrial Neoplasms 23Breast Neoplasms 11Fallopian Tube Neoplasms 7Vulvar Neoplasms 6Uterine Neoplasms 6Carcinoma, Ovarian Epithelial 6Colorectal Neoplasms, Hereditary Nonpolyposis 5Colorectal Neoplasms 5Colonic Neoplasms 5Vaginal Neoplasms 4Neoplasms 4Uterine Cervical Dysplasia 3Rectal Neoplasms 3Prostatic Neoplasms 3Pelvic Neoplasms 3Hereditary Breast and Ovarian Cancer Syndrome 3Vomiting 2Urinary Bladder Neoplasms 2Sarcoma 2Obesity 2Nausea 2Motor Activity 2Lymphoma, Non-Hodgkin 2Lymphoma 2Lymphedema 2Leukemia 2Kidney Neoplasms 2Gynecologic Cancer 2

Interventions

Surveys and Questionnaires 1Standard of Care 1Interviews as Topic 1High-Throughput Nucleotide Sequencing 1Genetic Testing 1Genetic Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Syndromes, Hereditary × Surveys and Questionnaires × Gynecologic × Clear all
NCT04763915 2025-09-19

IMPACT

Vanderbilt-Ingram Cancer Center

Phase NA Active not recruiting
720 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡